STEREOTAXIS, INC. Net Change in Cash
STEREOTAXIS, INC. (STXS) reported Net Change in Cash of -$2.93 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-08-12
- STEREOTAXIS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2026-03-31 was $1.20M.
- STEREOTAXIS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was -$1.75M.
- STEREOTAXIS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was -$2.32M.
- STEREOTAXIS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was -$3.10M.
- STEREOTAXIS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2025 was $985.00K.
- STEREOTAXIS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was -$8.13M, a 175.89% decline from fiscal 2023.
- STEREOTAXIS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was $10.71M.
- STEREOTAXIS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$30.29M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.93M 10-Q · filed 2026-08-12 | |||||||
| 2026-03-31 | $1.20M 10-Q · filed 2026-05-13 | |||||||
| 2025-12-31 | $985.00K 10-K · filed 2026-03-12 | |||||||
| 2025-09-30 | -$1.93M 10-Q · filed 2025-11-12 | |||||||
| 2025-06-30 | -$5.47M 10-Q · filed 2026-08-12 | |||||||
| 2025-03-31 | -$1.75M 10-Q · filed 2026-05-13 | |||||||
| 2024-12-31 | -$8.13M 10-K · filed 2026-03-12 | |||||||
| 2024-09-30 | -$9.55M 10-Q · filed 2025-11-12 | |||||||
| 2024-06-30 | -$5.40M 10-Q · filed 2025-08-13 | |||||||
| 2024-03-31 | -$2.32M 10-Q · filed 2025-05-13 | |||||||
| 2023-12-31 | $10.71M 10-K · filed 2025-03-14 | |||||||
| 2023-09-30 | $13.12M 10-Q · filed 2024-11-14 | |||||||
| 2023-06-30 | $14.07M 10-Q · filed 2024-08-14 | |||||||
| 2023-03-31 | -$3.10M 10-Q · filed 2024-05-15 | |||||||
| 2022-12-31 | -$30.29M 10-K · filed 2024-03-08 | |||||||
| 2022-09-30 | -$7.71M 10-Q · filed 2023-11-13 | |||||||
| 2022-06-30 | -$5.02M 10-Q · filed 2023-08-11 | |||||||
| 2022-03-31 | -$3.29M 10-Q · filed 2023-05-12 | |||||||
| 2021-12-31 | -$3.80M 10-K · filed 2023-03-09 | -$3.80M 10-K · filed 2022-03-10 | ||||||
| 2021-09-30 | -$1.39M 10-Q · filed 2022-11-14 | -$1.39M 10-Q · filed 2021-11-12 | ||||||
| 2021-06-30 | -$19.00K 10-Q · filed 2022-08-11 | -$18.39K 10-Q · filed 2021-08-12 | ||||||
| 2021-03-31 | -$57.00K 10-Q · filed 2022-05-11 | -$57.47K 10-Q · filed 2021-05-13 | ||||||
| 2020-12-31 | $13.76M 10-K · filed 2022-03-10 | |||||||
| 2020-09-30 | $13.41M 10-Q · filed 2021-11-12 | |||||||
| 2020-06-30 | $13.82M 10-Q · filed 2021-08-12 | |||||||
| 2020-03-31 | -$2.16M 10-Q · filed 2021-05-13 | |||||||
| 2019-12-31 | $19.39M 10-K · filed 2021-03-12 | |||||||
| 2019-09-30 | $20.85M 10-Q · filed 2020-11-09 | |||||||
| 2019-06-30 | -$2.32M 10-Q · filed 2020-08-06 | |||||||
| 2019-03-31 | -$1.76M 10-Q · filed 2020-05-11 | |||||||
| 2018-12-31 | $7.11M 10-K · filed 2020-03-16 | |||||||
| 2018-09-30 | $7.88M 10-Q · filed 2019-11-14 | |||||||
| 2018-06-30 | $8.31M 10-Q · filed 2019-08-09 | |||||||
| 2018-03-31 | $7.93M 10-Q · filed 2019-05-09 | |||||||
| 2017-12-31 | -$4.82M 10-K · filed 2019-03-15 | |||||||
| 2017-09-30 | -$4.01M 10-Q · filed 2018-11-13 | |||||||
| 2017-06-30 | -$3.47M 10-Q · filed 2018-08-08 | |||||||
| 2017-03-31 | -$2.76M 10-Q · filed 2018-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |